Value Investor, Frontier Asia Capital

Winston Chu

Value Investor

Frontier Asia Capital

Equity Bottom-Up

Sientra's 1Q16 results came out and flew under the radar despite spectacular progress in re-establishing the business.  In short, since returning to the U.S. market on March 1, 2016 the company's product volume pipeline has recovered substantially.Key comments from management:<blockquote>
Jeffrey Nugent
Let me describe our market re-entry strategy. Demand has exceeded our expectations in the first months of commercial activity. Since the market re-entry, we have contacted 84% of our total previous customers…
</blockquote>

Sientra's 1Q16 results came out and flew under the radar despite spectacular progress in re-establishing the business.  In short, since returning to the U.S. market on March 1, 2016 the company's product volume pipeline has recovered substantially.Key comments from management:
Jeffrey Nugent
Let me describe our market re-entry strategy. Demand has exceeded our expectations in the first months of commercial activity. Since the market re-entry, we have contacted 84% of our total previous customers…


Misfortune and uncertainty has left Sientra trading below liquidation value.  The tangible impact on the business is minimal while the uncertainties are simple to resolve.  The company has demonstrated impressive growth and operates in an industry with significant barriers to entry and unorganized incumbents.

Misfortune and uncertainty has left Sientra trading below liquidation value.  The tangible impact on the business is minimal while the uncertainties are simple to resolve.  The company has demonstrated impressive growth and operates in an industry with significant barriers to entry and unorganized incumbents.

United States

Sientra, Inc. manufactures and markets plastic surgery implantable devices. The Company focuses on developing plastic surgery and aesthetics medicine such as cosmetic and reconstructive surgical devices including breast implants, tissue expanders, body contouring implants, and other specialty products. Sientra serves customers throughout the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sientra (SIEN US)

Sientra - Impressive Revival

Sientra's 1Q16 results came out and flew under the radar despite spectacular progress in re-establishing the business. In short, since returning...

Winston Chu

Sientra - Sheer Value

Misfortune and uncertainty has left Sientra trading below liquidation value. The tangible impact on the business is minimal while the...

Winston Chu

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)